{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:10:59Z","timestamp":1792001459450,"version":"4.4.0"},"reference-count":0,"publisher":"Portico","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2020.56.4.3107707","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T09:22:23Z","timestamp":1586424143000},"page":"269","source":"Crossref","is-referenced-by-count":37,"title":["Oliceridine, a G protein-selective ligand at the mu-opioid\nreceptor, for the management of moderate to severe acute pain"],"prefix":"10.3730","volume":"56","author":[{"family":"Gan, T.J.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Wase, L.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1320","published-online":{"date-parts":[[2020]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T09:41:50Z","timestamp":1685439710000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7ddn8qp"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2020.56.4.3107707","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737789530.793581986","asserted-by":"object"}]},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}